Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flagship Biotech International is a Mumbai-based pharmaceutical company that specializes in the manufacturing, marketing, and export of a diverse range of pharmaceutical formulations. Established in 2009, the company has built a robust portfolio covering therapeutic areas such as oncology, cardiology, gastroenterology, and infectious diseases. Flagship Biotech is recognized as a significant player in the global generics market, exporting high-quality medicines to over 75 countries across Africa, Latin America, and Southeast Asia. The company operates state-of-the-art manufacturing facilities that comply with international quality standards, including WHO-GMP certifications. In addition to its product sales, Flagship Biotech offers contract manufacturing services and dossier development to international partners, facilitating access to affordable healthcare solutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flagship Biotech International.